EF5: Clinical Trials

5 trials of EF5, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 2 completed. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Terminated 3, Completed 2

Follow EF5: new trials by email Literature Review of EF5 trials Research Report on EF5

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Imaging and Biomarkers of Hypoxia in Solid Tumors
PET Scan, EF5, Carbogen - Neoplasms
Phase 1TerminatedStanford University282010-12-012017-11-06
Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers
Dichloroacetate, EF5 - Head and Neck Cancer, Head and Neck Cancers
Phase 1CompletedDaniel T. Chang172010-08-012022-06-16
Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
EF5, conventional surgery, positron emission tomography - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma
Phase 1TerminatedNational Cancer Institute (NCI)462005-06-012013-01-16
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
EF5, flow cytometry, fluorescent antibody technique - Breast Cancer, Cervical Cancer
Phase 1TerminatedUniversity Health Network, Toronto1999-12-012018-02-22
EF5 in Treating Patients With Solid Tumors
EF5, therapeutic conventional surgery, biopsy - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedNational Cancer Institute (NCI)501998-03-012013-01-16

Conditions studied

Head and Neck Neoplasms (2)  ·  Astrocytoma (1)  ·  Breast Carcinoma In Situ (1)  ·  Breast Neoplasms (1)  ·  Choroid Plexus Neoplasms (1)  ·  Craniopharyngioma (1)  ·  Ependymoma (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Glioma, Subependymal (1)  ·  Gliosarcoma (1)  ·  Hypopharyngeal Neoplasms (1)  ·  Inflammatory Breast Neoplasms (1)  ·  Laryngeal Neoplasms (1)  ·  Medulloblastoma (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Daniel T. Chang (1)  ·  Stanford University (1)  ·  University Health Network, Toronto (1)

Countries

United States (4)  ·  Canada (1)

Top investigators

Stephen Michael Hahn (2)  ·  Anthony Fyles, MD (1)  ·  Daniel T Chang (1)

NIH funding

R01CA075285 (1)